These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2416231)

  • 1. Chemotherapy to increase fetal hemoglobin in patients with sickle cell anemia.
    Platt OS
    Am J Pediatr Hematol Oncol; 1985; 7(3):258-60. PubMed ID: 2416231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress toward increasing fetal hemoglobin production in man: experience with 5-azacytidine and hydroxyurea.
    Dover GJ; Charache S; Nora R; Boyer SH
    Ann N Y Acad Sci; 1985; 445():218-24. PubMed ID: 2409873
    [No Abstract]   [Full Text] [Related]  

  • 3. Increasing fetal hemoglobin in sickle cell disease: comparisons of 5-azacytidine (subcutaneous or oral) with hydroxyurea.
    Dover GJ; Charache S; Boyer SH
    Trans Assoc Am Physicians; 1984; 97():140-5. PubMed ID: 6085527
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?
    Fathallah H; Sutton M; Atweh GF
    Ann N Y Acad Sci; 2005; 1054():228-37. PubMed ID: 16339670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Azacytidine and fetal hemoglobin.
    Heller P; DeSimone J
    Am J Hematol; 1984; 17(4):439-47. PubMed ID: 6208778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA
    Adv Pediatr; 1996; 43():309-34. PubMed ID: 8794181
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease.
    Atweh GF; Schechter AN
    Curr Opin Hematol; 2001 Mar; 8(2):123-30. PubMed ID: 11224687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fetal hemoglobin].
    Rokicka-Piotrowicz M
    Postepy Hig Med Dosw; 1989; 43(5-6):475-97. PubMed ID: 2484927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea induction of fetal hemoglobin synthesis in sickle-cell disease.
    Dover GJ; Charache S
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):61-6. PubMed ID: 1379374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy and hemoglobin F synthesis in sickle cell disease.
    Dover GJ; Charache S
    Ann N Y Acad Sci; 1989; 565():222-7. PubMed ID: 2476061
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacologic manipulation of fetal hemoglobin. Update on clinical trials with hydroxyurea.
    Dover GJ
    Ann N Y Acad Sci; 1990; 612():184-90. PubMed ID: 1705407
    [No Abstract]   [Full Text] [Related]  

  • 12. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea.
    Veith R; Galanello R; Papayannopoulou T; Stamatoyannopoulos G
    N Engl J Med; 1985 Dec; 313(25):1571-5. PubMed ID: 2415821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
    N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience.
    Rodgers GP
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):67-73. PubMed ID: 1379375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic stimulation of Hb F in patients with sickle cell anemia.
    Galanello R; Veith R; Papayannopoulou T; Stamatoyannopoulos G
    Prog Clin Biol Res; 1985; 191():433-45. PubMed ID: 2413479
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological induction of fetal hemoglobin synthesis using histone deacetylase inhibitors.
    Cao H
    Hematology; 2004 Jun; 9(3):223-33. PubMed ID: 15204104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of hemoglobin F synthesis in patients with beta thalassemia.
    Ley TJ; Nienhuis AW
    Annu Rev Med; 1985; 36():485-98. PubMed ID: 2581500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal hemoglobin, sickling, and sickle cell disease.
    Charache S
    Adv Pediatr; 1990; 37():1-31. PubMed ID: 1702260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
    Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia.
    Koshy M; Dorn L; Bressler L; Molokie R; Lavelle D; Talischy N; Hoffman R; van Overveld W; DeSimone J
    Blood; 2000 Oct; 96(7):2379-84. PubMed ID: 11001887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.